Search Results

Amid an unprecedented turnover in leadership at the FDA and mass layoffs of staff, communication has crumbled and uncertainty runs rampant, leaving small and medium biopharma companies without a clear path forward for their therapies.

Rick Doblin, the founder of the Multidisciplinary Association for Psychedelic Studies, which founded Lykos, bemoaned a “moving of the goal posts” in Lykos’ rejection but looked for positives in the newly released complete response letter.

New thought leadership highlights the foundational role of data orchestration in enabling intelligent automation and Service-as-Software in biopharma.

Robert F. Kennedy Jr. repeated a series of anti-vaccine talking points during his appearance in front of the Senate finance committee on Thursday, as Democratic and Republican senators alike hammered the Health Secretary on recent COVID-19 vaccine restrictions and his views on Operation Warp Speed.

Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.

ASGCT’s “Advancing Cell and Gene Therapies for Cancer” is a 1.5 day conference taking place October 15-16, 2025, at the Philadelphia Marriott Downtown, focusing on the latest research in cell and gene therapies for cancer treatment. Attendees will explore cutting-edge advancements in oncolytic viruses, cell and immunotherapies, and combination approaches designed to improve patient outcomes while tackling critical challenges like tumor heterogeneity and delivery limitations.